V015-1641 Screening compound: 4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]-N,N-dipropylbenzamide

V015-1641 Screening compound: 4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]-N,N-dipropylbenzamide
V015-1641 Screening compound: 4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]-N,N-dipropylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-1641
4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]-N,N-dipropylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-1641

Molecular Formula

C26H28FN5O2 (C26 H28 FN5 O2)

Compound Name

4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]-N,N-dipropylbenzamide

IUPAC name

4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-134-oxadiazol-2-yl)-1H-pyrazol-1-yl]-NN-dipropylbenzamide

SMILES

CCCN(CCC)C(c(cc1)ccc1-n(c(-c(cc1)ccc1F)c1C)nc1-c1nnc(C)o1)=O

InChI

InChI=1S/C26H28FN5O2/c1-5-15-31(16-6-2)26(33)20-9-13-22(14-10-20)32-24(19-7-11-21(27)12-8-19)17(3)23(30-32)25-29-28-18(4)34-25/h7-14H,5-6,15-16H2,1-4H3

InChI Key

LIRPBWGKDICMHH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19948210

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.316

Distribution Coefficient, logD

4.316

Water Solubility, LogSw

-4.13

Polar Surface Area

59.791

Acid Dissociation Constant (pKa)

23.05

Base Dissociation Constant (pKb)

0.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.77

V015-1641 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Cardiovascular Library (22201 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cardiovascular
  • Cancer
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V015-1641 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-1641?
Check Price and Availability of V015-1641, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-1641 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-1641
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-1641
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-1641 available by request